Brief: Guard Therapeutics Q3 Loss SEK 26.1 Mln
Nov 13 (Reuters) - Guard Therapeutics International AB (publ) GUARD.ST: Q3 NET SALES 0 KSEK, PROFIT -26,085 KSEK, EPS -1.29 SEK Source text: ID:nMFN5BfzV6 Further company coverage: GUARD.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover